How to Avoid Expensive Redesign Cycles in Antibody Discovery
Learn how integrated antibody discovery and engineering strategies can accelerate the path from hit to optimized lead in less than 12 months while minimizing costly redesign cycles.
Accelerating Antibody Discovery: Integrating Microfluidics, HT Expression, and Early Developability Platform
In this webinar, Dr. Lei Shi introduces Biointron's antibody discovery platform and applications.
Next-Generation TCR-Like Antibodies With Improved Specificity Profiles
Discover how YUMAB’s pHLA display library identifies highly specific TCR-like antibodies to target undruggable cancer epitopes with improved safety profiles.
ADCs on The Horizon: The Performance and Prospect of Cell Line Development Platform — AmigoCHO™
Dr. Jiawen Xu presents AsymBio’s AmigoCHO™ platform and "CLD toolbox" strategies designed to accelerate cell line development and overcome CMC bottlenecks for complex antibody and ADC programs.
From Single Domain to Single B: Leveraging Biointron’s Expertise for Antibody Discovery Success
In this webinar, we present Biointron’s proven expertise in two discovery approaches: VHH Phage Display for single-domain antibody generation and AbDrop® Single B Cell Screening for rapid antibody discovery.
Introduction to Bispecific Antibodies and Their Production
In this webinar, Dr. Brady Wu discusses bispecific antibody drugs and their production.
Innovative Rabbit Antibodies and Engineering for Therapeutics and Diagnostics
In this webinar, Abwiz Bio scientists present innovative methods for developing rabbit monoclonal antibodies for therapeutic and diagnostic applications, showcasing cutting-edge phage display and antibody engineering techniques.
#ExpertAnswers: Amy Sheng on Antibody Screening and Discovery
Amy Sheng provides an overview of antibody screening platforms and presents applications and case studies using the Beacon® platform for antibody discovery.
Antibody Discovery by Single B Cell Screening on Beacon®
Amy Sheng, PhD provides an overview of antibody screening platforms and presents applications and case studies using the Beacon® platform for antibody screening.
#ExpertAnswers: Yuning Chen on Antibody Production
Yuning Chen discusses strategies involved in recombinant antibody production and introduces a novel antibody expression platform to facilitate antibody library generation.
Recombinant Antibody Production: Current Methods and a Novel Antibody Generation Platform
Dr. Yuning Chen discusses strategies involved in recombinant antibody production and introduce a novel antibody expression platform to facilitate antibody library generation.
Cutting Edge Conversations: Addressing COVID-19 During Uncertainty
Hayley Crawford, PhD, and Carl Marci, MD, discuss how their specific industries have developed new innovations in response to the COVID-19 pandemic.
Cutting Edge Conversations: Biomarkers – Challenges and Opportunities
The 5th and final episode in the Cutting Edge Conversation series for 2021 features Dr. Morad Nakhleh, Natalie Smith, and Dr. Bhavika Patel as they discuss industry challenges and innovations surrounding biomarkers in life science research and precision medicine
#ExpertAnswers: Jiahui Yang on Antibody Discovery Platforms
Dr. Jiahui Yang provides an overview of antibody discovery platforms and discusses how single B cell sorting can be used to generate functional monoclonal antibodies for a range of applications including disease diagnosis and therapeutics.
Plasma Proteomics: The Next Frontier of Biomarker Discovery in the Precision Medicine Era
Plasma proteomics is increasingly recognized as a fundamental approach to accelerate biomarker discovery and drug development, taking precision medicine to the next level.
Antibody Discovery Platforms to Support Functional Monoclonal Antibody Generation
Join Dr. Jiahui Yang as she provides an overview of antibody discovery platforms and discusses how single B cell sorting can be used to generate functional monoclonal antibodies for a range of applications.
